Study details
Enrolling now
IH, Brain Health, and T2D
Darren P Casey
NCT IDNCT07173543ClinicalTrials.gov data as of Apr 2026
Target enrollment
80
Study length
about 2.8 years
Ages
60–85
Locations
1 site in IA
What this study is about
Researchers are testing whether intermittent hypoxia can improve brain health in older adults with or without type 2 diabetes. The trial will last for 1012 days and involve approximately 80 participants who will be randomly assigned to either intermittent hypoxia or a sham treatment.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Intermittent Hypoxia 1 (IH1)
- 2.Intermittent Hypoxia 2 (IH2)
- 3.SHAM - normoxia
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
Randomized (Open Label)
You are randomly assigned, but you will know your treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Body systems
Endocrinology